First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis-Reference-Cited by-同舟云学术

First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis

Published:2021-10 Issue:5 Volume:4 Page:755-765
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Quhal Fahad^ORCID,Mori Keiichiro,Bruchbacher Andreas,Resch Irene,Mostafaei Hadi,Pradere Benjamin,Schuettfort Victor M.,Laukhtina Ekaterina,Egawa Shin,Fajkovic Harun,Remzi Mesut,Shariat Shahrokh F.,Schmidinger Manuela

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference31 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Overview of current and future first-line systemic therapy for metastatic clear cell renal cell carcinoma;Gill;Curr Treat Options Oncol,2018

3. Targeted therapies for renal cell carcinoma;Posadas;Nat Rev Nephrol,2017

4. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma;Motzer;N Engl J Med,2018

5. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Motzer;N Engl J Med,2019

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safety;Urologic Oncology: Seminars and Original Investigations;2024-11

2. Long-Term Temporal Trends of Real-World Healthcare Costs Associated with Nivolumab Plus Ipilimumab and Pembrolizumab Plus Axitinib as First-Line Treatment for Advanced or Metastatic Renal Cell Carcinoma;Oncology and Therapy;2024-08-10

3. Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis;Health Technology Assessment;2024-08

4. Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors;Journal of Immunotherapy;2024-07-11

5. International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study);BMC Cancer;2024-06-24